뉴스
- Kolon crashes on TG-C failure; NGeneBio soars [K-bio pulse] Shares of three Kolon Group affiliates tumbled Tuesday after Kolon TissueGene's osteoarthritis cell and gene therapy TG-C — formerly known as Invossa &mda
- Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse] On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnolo
- i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market exp
블로그
- 2026.6.12 - SpaceX, Now Worth $2.1 Trillion/ 앤트로픽, 미국 정부의 해외 사용 금지 조치에 따라 주요 AI 모델 접근 차단/일본은행이 다음 주 Stocks Climb on SpaceX’s Debut By Heard on the Street Staff June 13, 2026 Indexes Settle Higher as SpaceX Soars in Trading Debut By Vicky Ge Huang June 13, 2026 뉴시스 뉴욕증시, '이란 종전' 가시화에 급등 마감…유가는 90달러선으로 김승민
- Oil prices soar 5% after non-OPEC producers agree to cut output http://www.marketwatch.com/story/oil-soars-nearly-5-after-non-opec-producers-agree-to-cut-output-2016 -12-12‘OPEC has overcome a significant hurdle,’ says analyst Crude futures surged by more than 4% on
- BMS의 Opdivo 임상3상 실패 소식에 대하여 지난주 금요일 밤, 다음날 있던 발표 준비를 마무리하고 자기 전에 뉴스를 보려고 Fierce Biotech 홈페이지에 들어갔는데, 메인 기사로 "Merck soars BMS tumbles on Opdivo fail in first-line NSCLC"라는 제목의 메인 기사가 홈페이지를 장식하고 있었다.